Accra

Home Accra

Todas las noticias

Accra

Jan 11, 2025

SN BioScience Propels SNB-101 to Phase 2 with IND Clearance from FDA

SEOUL,South Korea,Jan. 10,2025-- SNBioScience today announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for a

Accra

Jan 11, 2025

Triller Saves Creators' TikTok Content Ahead of Ban

LOS ANGELES,Jan. 10,2025-- Triller Corp,a creator-focused social media and live-streaming event platform,unveils the option for creators to preserve their TikTok content ahead of the congressional ma

Accra

Jan 11, 2025

State Grid Xuzhou Power Supply Company: Independent Implementation of "Perceptive Eyes" Installation for Critical Transmission Channels

XUZHOU,China,Jan. 10,2025--Recently,in the Daishan area of Xuzhou,Jiangsu Province,State Grid Xuzhou Power Supply Company has independently installed an advanced "infrared thermal imaging + visib

Accra

Jan 10, 2025

DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu

CAMBRIDGE,England and SAN DIEGO,Jan. 9,2025-- DIOSynVax,a clinical-stage biotechnology company at the forefront of developing innovative,broadly protective vaccines,built on the safety demonstrated by

Accra

Jan 10, 2025

Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development

Samsung Biologics to offer ADC services at new dedicated facility Extended collaboration reflects successful partnership and expertise

Accra

Jan 10, 2025

Invitation to media and analyst briefing for Ericsson Q4 2024 report

Report to be released at approximately 7:00 AM CET on January 24,2025 One live video webcast for analysts,investors,and journalists at 9:00 AM CET